Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice
Author
dc.contributor.author
Miranda, Hugo F.
Author
dc.contributor.author
Noriega, Viviana
Author
dc.contributor.author
Olavarria, Loreto
Author
dc.contributor.author
Zepeda, Ramiro J.
Author
dc.contributor.author
Sierralta, Fernando
Author
dc.contributor.author
Prieto, Juan C.
Admission date
dc.date.accessioned
2019-03-11T13:02:17Z
Available date
dc.date.available
2019-03-11T13:02:17Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Basic and Clinical Pharmacology and Toxicology, Volumen 109, Issue 6, 2018, Pages 438-442
Identifier
dc.identifier.issn
17427835
Identifier
dc.identifier.issn
17427843
Identifier
dc.identifier.other
10.1111/j.1742-7843.2011.00746.x
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165310
Abstract
dc.description.abstract
Statins, belonging to a well-known drug class used for lowering cholesterol through competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also have other pleiotropic properties, such as anti-inflammatory action. The purpose of this study was to evaluate the antinociceptive and anti-inflammatory effects of simvastatin in five models of nociceptive behaviour. Oral gavage administration of simvastatin induced a dose-dependent inhibition of nociception for 1day in the acetic acid writhing (ED 50=5.59±0.07), tail-flick (ED 50=112.96±8.00), hot-plate (ED 50= 134.87±2.20), formalin hind paw (ED 50=19.86±1.12 in phase I and 23.30±2.05 in phase II) and orofacial formalin (ED 50=5.54±2.74 in phase I and 11.48±1.88 in phase II) tests. However, after 3days, the values were in the acetic acid writhing (ED 50=6.14±0.51), tail-flick (ED 50=154±8.88), hot-plate (ED 50=136.14±2.94), formalin hind paw (ED 50=15.93±0.42 in phase I and 17.10±1.80 in phase II) and orofacial f